nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD
|
Navaneethan, Sankar D. |
|
|
77 |
1 |
p. 44-55 |
artikel |
2 |
2020 AJKD Editors’ Choice Awards
|
|
|
|
77 |
1 |
p. A13-A15 |
artikel |
3 |
Assessing Acid-Base Status in Patients With CKD: Does Measurement of Blood pH Matter?
|
Raphael, Kalani L. |
|
|
77 |
1 |
p. 9-11 |
artikel |
4 |
Association Between Midlife Physical Activity and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study
|
Parvathaneni, Kaushik |
|
|
77 |
1 |
p. 74-81 |
artikel |
5 |
Can We Study Hypertension in Patients on Dialysis? Yes We Can
|
Georgianos, Panagiotis I. |
|
|
77 |
1 |
p. 4-6 |
artikel |
6 |
Corticosteroids and COVID-19: What Could Be the Best Bet in Treating Active Glomerular Diseases in Patients With Concomitant Early COVID-19?
|
Nayak, Saurabh |
|
|
77 |
1 |
p. 154-155 |
artikel |
7 |
Editorial Board
|
|
|
|
77 |
1 |
p. A2-A3 |
artikel |
8 |
Favipiravir for COVID-19 in a Patient on Hemodialysis
|
Hirai, Daisuke |
|
|
77 |
1 |
p. 153-154 |
artikel |
9 |
In Case of a Pandemic, Pivot: Moving the National Kidney Foundation Spring Clinical Meeting Online
|
Kramer, Holly |
|
|
77 |
1 |
p. 1-3 |
artikel |
10 |
2020 Inductees to the AJKD Reviewer Hall of Fame
|
|
|
|
77 |
1 |
p. A11-A12 |
artikel |
11 |
In Reply to ‘Response to the KDOQI US Commentary on the 2018 KDIGO Hepatitis C Guideline’
|
Reese, Peter P. |
|
|
77 |
1 |
p. 152-153 |
artikel |
12 |
Invasive Versus Conservative Management of Stable Coronary Artery Disease in CKD
|
McCallum, Wendy |
|
|
77 |
1 |
p. 149-151 |
artikel |
13 |
Masthead
|
|
|
|
77 |
1 |
p. A1 |
artikel |
14 |
Modulation of the Association of Hypobicarbonatemia and Incident Kidney Failure With Replacement Therapy by Venous pH: A Cohort Study
|
Kajimoto, Sachio |
|
|
77 |
1 |
p. 35-43 |
artikel |
15 |
Multicenter Clinicopathologic Correlation of Kidney Biopsies Performed in COVID-19 Patients Presenting With Acute Kidney Injury or Proteinuria
|
Akilesh, Shreeram |
|
|
77 |
1 |
p. 82-93.e1 |
artikel |
16 |
Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
|
Anderson, Amanda H. |
|
|
77 |
1 |
p. 56-73.e1 |
artikel |
17 |
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program
|
Neuen, Brendon L. |
|
|
77 |
1 |
p. 23-34.e1 |
artikel |
18 |
Resistant Hypertension in People With CKD: A Review
|
Fay, Kevin S. |
|
|
77 |
1 |
p. 110-121 |
artikel |
19 |
Response to the KDOQI US Commentary on the 2018 KDIGO Hepatitis C Guideline
|
Kamar, Nassim |
|
|
77 |
1 |
p. 152 |
artikel |
20 |
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
|
Tuttle, Katherine R. |
|
|
77 |
1 |
p. 94-109 |
artikel |
21 |
State-of-the-Art Management of Hyperphosphatemia in Patients With CKD: An NKF-KDOQI Controversies Perspective
|
Scialla, Julia J. |
|
|
77 |
1 |
p. 132-141 |
artikel |
22 |
Table of Contents
|
|
|
|
77 |
1 |
p. A5-A8 |
artikel |
23 |
Telehealth for Home Dialysis in COVID-19 and Beyond: A Perspective From the American Society of Nephrology COVID-19 Home Dialysis Subcommittee
|
Lew, Susie Q. |
|
|
77 |
1 |
p. 142-148 |
artikel |
24 |
The Evolving Role of Novel Biomarkers in Glomerular Disease: A Review
|
Cavanaugh, Corey |
|
|
77 |
1 |
p. 122-131 |
artikel |
25 |
Treating Home Versus Predialysis Blood Pressure Among In-Center Hemodialysis Patients: A Pilot Randomized Trial
|
Bansal, Nisha |
|
|
77 |
1 |
p. 12-22 |
artikel |
26 |
Use of Point-of-Care Ultrasound to Assess CKD
|
Reisinger, Nathaniel |
|
|
77 |
1 |
p. A16-A19 |
artikel |
27 |
What Is the Utility of KDIGO Criteria to Identify High-Risk Populations?
|
Wanner, Christoph |
|
|
77 |
1 |
p. 7-8 |
artikel |